Is candidemia considered a contaminant rather than a true bloodstream infection?

Candidemia is NOT a Contaminant

Candidemia should always be treated as a true bloodstream infection requiring immediate antifungal therapy, not dismissed as contamination. Unlike coagulase-negative staphylococci or other skin flora that may represent contamination, Candida species isolated from blood cultures represent genuine invasive infection with significant mortality risk.

Why Candidemia is Never Contamination

The IDSA guidelines 111111 provide extensive treatment algorithms for candidemia, emphasizing:

• Mandatory treatment for 2 weeks after documented clearance from bloodstream and symptom resolution (strong recommendation)
• Required ophthalmologic examination within the first week after diagnosis (strong recommendation)
• Daily or every-other-day follow-up blood cultures to establish clearance (strong recommendation)
• Central venous catheter removal as early as possible (strong recommendation)

These recommendations would not exist if candidemia were ever considered contamination. The guidelines treat every positive blood culture for Candida as clinically significant.

Clinical Significance and Mortality

Candidemia represents one of the most common healthcare-associated bloodstream infections 1:

• Third or fourth most common hospital-acquired bloodstream isolate in many US hospitals
• High mortality rates: ICU mortality reaches 42.6% 2, with overall mortality rates of 23.4% at 14 days and 55.3% in-hospital 3
• Earlier therapy associated with better outcomes 1
• Prolonged ICU stays: median 33 days compared to 20-21 days for bacterial bloodstream infections 2

Detection Methods Confirm True Infection

When Candida is detected in blood, it represents genuine fungemia 4:

• Blood culture remains the gold standard for diagnosis
• Peripheral blood smear detection (showing pseudohyphae among RBCs and phagocytosed blastospores in neutrophils/monocytes) is extremely rare but confirms true infection, not contamination
• Detection by PBS is considered an emergency requiring immediate antifungal treatment 4

Risk Factors Indicate Invasive Disease

The extensive list of risk factors in guidelines 15 demonstrates that candidemia occurs in specific high-risk populations with genuine invasive disease:

• Recent abdominal surgery
• Central venous catheters
• Prolonged ICU stay
• Broad-spectrum antibiotics
• Acute renal failure
• Parenteral nutrition
• Immunosuppression/neutropenia
• Mucosal colonization (particularly multifocal)

Treatment Mandates Confirm Clinical Significance

The aggressive treatment approach required 111 further confirms candidemia is never contamination:

• Immediate echinocandin therapy (caspofungin, micafungin, or anidulafungin) as first-line for most patients
• Source control with catheter removal
• Imaging for metastatic complications (CT/ultrasound of genitourinary tract, liver, spleen)
• Minimum 2 weeks of therapy after clearance

Common Pitfall to Avoid

Never dismiss a positive Candida blood culture as contamination. This is a critical error that leads to delayed treatment and increased mortality. Unlike skin flora that may represent contamination in blood cultures, Candida species in blood always warrant:

1. Immediate antifungal therapy initiation
2. Source control evaluation
3. Removal of central venous catheters when feasible
4. Daily follow-up cultures until clearance
5. Ophthalmologic examination
6. Imaging for metastatic disease if cultures remain positive

The concept of "contamination" does not apply to candidemia in clinical practice.